首页> 外文OA文献 >Efficacy and safety of sarilumab in combination with methotrexate in patients with active rheumatoid arthritis and inadequate effect of methotrexate monotherapy (results of phase III MOBILITY study)

【2h】

Efficacy and safety of sarilumab in combination with methotrexate in patients with active rheumatoid arthritis and inadequate effect of methotrexate monotherapy (results of phase III MOBILITY study)

机译：Sarilumab与甲氨蝶呤在有活性类风湿性关节炎患者中的疗效和安全性和甲氨蝶呤单疗法的疗效（III期迁移率研究的结果）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
E. L. Nasonov; M. L. Stanislav; T. A. Raskina; G. V. Kuropatkin; I. V. Shirinsky; A. P. Rebrov; N. A. Shostak; B. A. Alikhanov; E. N. Ushakov; R. G. Kamalova; S. A. Smakotina; V. I. Simanenkov; A. S. Pavsun; I. I. Zaharjan; S. S. Yakushin; M. Yu. Sandin;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study [J] . Bi L., Li Y., He L., Clinical and experimental rheumatology . 2019,第2期

机译：Certolizumab Pegol与甲氨蝶呤在甲氨蝶呤 - 不足的响应者中的抑制剂的疗效和安全性 - 活性类风湿性关节炎患者：24周的随机，双盲，安慰剂控制第3期研究
2. Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies [J] . Mark C. Genovese, Roy Fleischmann, Alan Kivitz, Arthritis research & therapy. . 2020,第1期

机译：Sarilumab与CSDMARD组合或作为患者患者的单药治疗在三期III的三阶段患者中的单药治疗的疗效和安全性
3. Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate [J] . Matsuno Hiroaki, Tomomitsu Masato, Hagino Atsushi, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第4期

机译：III期，多期，双盲，随机，并行群体研究，以评估LBEC0101和涅安普科学版之间的相似性，在有活性类风湿性关节炎患者的疗效和安全性方面，不充分应对甲氨蝶呤
4. Symptomization of Rheumatoid Arthritis in Patients on Pathological Examination: A Case Study [C] . Saurav Bharadwaj, Pallab Sarma IEEE International Students' Conference on Electrical, Electronics and Computer Science . 2020

机译：类风湿关节炎症状的病理检查：案例研究
5. Development and characterization of methotrexate loaded poly(L-lactic acid) microspheres for the treatment of rheumatoid arthritis. [D] . Liang, Sanching Linda. 2006

机译：甲氨蝶呤负载聚（L-乳酸）微球的开发和表征，用于治疗类风湿关节炎。
6. Extended report: Phase III multicentre double-blind randomised parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate [O] . Hiroaki Matsuno, Masato Tomomitsu, Atsushi Hagino, -1

机译：扩展报告：III期多中心双盲随机平行分组研究以评估对甲氨蝶呤反应不良的活动性类风湿性关节炎患者LBEC0101和依那西普参考产品之间在有效性和安全性方面的相似性
7. Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial [O] . Vibeke Strand, Mark Kosinski, Chieh-I Chen, 2016

机译：Sarilumab联合甲氨蝶呤改善了活动性类风湿关节炎患者对甲氨蝶呤反应不足的患者报告的结果：一项III期试验的结果

Efficacy and safety of sarilumab in combination with methotrexate in patients with active rheumatoid arthritis and inadequate effect of methotrexate monotherapy (results of phase III MOBILITY study)

著录项

引文网络

相似文献

相关主题

期刊订阅